newsfilter
← Latest News
GlobeNewswire·

COMP adopts positive opinion on Orphan Disease Designation for Mycapssa® for the treatment of Acromegaly

COMP adopts positive opinion on Orphan Disease Designation for Mycapssa® for the treatment of Acromegaly DUBLIN, Ireland, and Boston MA, October 18, 2022 Amryt (NASDAQ:AMYT), a global, commercial-stage